Technology Innovation, People Centric
Adhering to the mission of providing trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, Endovastec™ is committed to building a leading enterprise of emerging technologies in great vessel surgery and peripheral vascular medicine.
Products
Endovastec™ focuses on the research and development (R&D), manufacturing, sales and services of aortic, peripheral vascular and tumor intervention devices,and our main products are thoracic and abdominal aortic stent grafts, stent grafts in surgical operation, peripheral vascular stents, drug-coated balloon dilatation catheters, balloon dilatation catheters, vena cava filters and snare retrieval kits etc.
News
Endovastec™ Completes First Commercial Use of Minos™ in the Netherlands
Endovastec™ recently announced the first two commercial uses of its Minos™ Abdominal Aortic Stent Graft and Delivery System (Minos™) in the Netherlands.
26 Sept 2025
Endovastec™’s Cratos™ Completes First Commercial Use in Hungary
Endovastec™ recently announced the first commercial use of its Cratos™ Thoracic Branch Stent Graft System (Cratos™) in Hungary. The procedure was performed by Dr. Gabor Kasza, Dr. Gabor Fazekas, and their team at University of Pecs Medical School in Pecs, Hungary.
12 Sept 2025
Endovastec™ Completes First Commercial Implantation of Minos™ in Ecuador and Hercules™-LP in Malaysia
Recently, Endovastec™ achieved two notable milestones in the aortic and peripheral vascular fields.
06 Aug 2025